Scientists from Australia, the Uk and the netherlands pose to use against the coronavirus, which is given to newborns to stop tb.
A vaccine was created in the decade of the 1920 could serve for the coronavirus.
According to a group of scientists of various nationalities, this medication could be effective. One of the functions of the BCG vaccine is to be tuberculosis, boosting the immune system of a patient.
Coronavirus and possible vaccine
The various clinical trials to test this vaccine are being carried out by experts of various nationalities.
Among them there are scientists in the United Kingdom, Australia and the netherlands. The vaccine, known as Bacille Calmette-Guerin (BCG) was developed in the 1920s. By that time, it was occupied as a treatment to address the disease of tuberculosis.
Now, scientists have been seen as a potential candidate to combat the pandemic of the COVID-19. According to previous results, this medication can reduce the prevalence and also to reduce the symptoms.
A group of researchers belonging to the Institute for Children’s Research Murdoch in Melbourne has tested. In total, it was applied a dose of the medication to more than 4,000 workers hospitals in the country.
“This trial will help to evaluate properly the effectiveness of the vaccine against the symptoms of the coronavirus”.
“If it could save the life of our heroic health care workers first-line”.
The research of the medication have joined experts from the United Kingdom and the netherlands. In these places also encentran doing tests to see the effectiveness of the medication.
A study conducted by the WHO in 2014 said that the BCG can reduce symptoms of respiratory infections.
However, your overall rating of trust granted by the Institution was poor, not getting by then a good evaluation. On the other hand, experts expect that this vaccine will be a bridge that successfully reduce symptoms and lower the dangers of coronavirus.
Though this is not the ultimate curecould be a door to reduce severe symptoms and help to fight off the consequences. A group of scientists belonging to the Max Planck Institute developed in the year 2001, a similar vaccine to BCG.
However, this is more modern and might be more effective, so that their trials will start soon in Germany. Finally, among the countries affected by the pandemic, currently Italy and the united States are the only ones that don’t have it available.
This occurs because both nations do not have a policy of universal vaccination with BCG, so that if it is effective, you must enable it.